National Epidemiological Study of the Possible Impact of Stress on Glycaemic Control in Patients With Type 1 Diabetes

NCT ID: NCT06365255

Last Updated: 2024-04-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1344 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-01-17

Study Completion Date

2024-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The EPISTRESS2 study is a one-off cross-sectional epidemiological survey, carried out via an online form in patients with type 1 diabetes followed up by participating investigating centres.

In type 1 diabetes (T1DM), studies on stress and its impact on glycaemia have led to ambiguous results, mainly because there are no solid epidemiological or experimental data in the literature. The aim of this study was to assess the impact of perceived stress on blood glucose levels in a population of subjects with T1DM at 10 national centres.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Type 1

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

questionnaires

filling in questionnaires

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with type 1 diabetes;
* Do not have a psychiatric pathology;
* At least 18 years old;
* Affiliated to the Social Security;
* Having read the non-opposition form and not objecting to it.

Exclusion Criteria

* Patient who has declared his opposition using the electronic non-opposition form
* Patient with type 2 diabetes
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sylvia Franc, MD

Role: PRINCIPAL_INVESTIGATOR

Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Angers University Hospital

Angers, , France

Site Status

Avignon Hospital

Avignon, , France

Site Status

St André Hospital

Bordeaux, , France

Site Status

Brest University Hospital

Brest, , France

Site Status

Dijon University Hospital

Dijon, , France

Site Status

CERITD

Évry, , France

Site Status

Grenoble University Hospital

Grenoble, , France

Site Status

Lille University Hospital

Lille, , France

Site Status

APHM- La Conception Hospital

Marseille, , France

Site Status

Private practice in endocrinology and metabolic diseases

Mérignac, , France

Site Status

Srasbourg University Hospital

Strasbourg, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-A01453-40

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Type 1 Diabetes Education and Support Study
NCT05735340 ACTIVE_NOT_RECRUITING NA
Decreasing Stress in Diabetes
NCT04016415 COMPLETED NA
Type 1 Diabetes and Diabetes Distress
NCT06936280 RECRUITING NA